Emerging at the UK, retatrutide, a new peptide , is creating considerable excitement within the healthcare community regarding its promise for weight regulation. This dual GIP and GLP-1 receptor agonist looks to deliver a substantial advantage over established therapies, showing promising results in preliminary clinical studies . Researchers believ